%0 Journal Article
%K Humans
%K *Aripiprazole/therapeutic use/adverse effects
%K Female
%K Male
%K Middle Aged
%K *Antipsychotic Agents/therapeutic use/adverse effects
%K Adult
%K *Mental Disorders/drug therapy
%K Quetiapine Fumarate/therapeutic use/adverse effects
%K Treatment Outcome
%K Risperidone/therapeutic use/adverse effects
%K Aged
%K Olanzapine/therapeutic use/adverse effects
%K Hospitalization/statistics & numerical data
%B PLoS Med
%D 2025
%G eng
%M 39847591
%P e1004520
%R 10.1371/journal.pmed.1004520
%T Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation
%V 22
%2 PMC11778676 following competing interests: JFH has received consultancy fees from Wellcome Trust and funding grants from juli Health unrelated to the results of the current study. All other authors declare no competing interests.
%7 2025/01/23
%@ 1549-1277 (Print)
1549-1277